Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives.

Factors that mediate increases in salt sensitivity of blood pressure with age remain to be clarified. The present study investigated 1) the effects of high-NaCl intake on two Na pump inhibitors, endogenous ouabain (EO) and marinobufagenin (MBG), in middle-aged and older normotensive Caucasian women; and 2) whether individual differences in EO and MBG are linked to variations in sodium excretion or salt sensitivity. A change from 6 days of a lower (0.7 mmol.kg(-1).day(-1))- to 6 days of a higher (4 mmol.kg(-1).day(-1))-NaCl diet elicited a sustained increase in MBG excretion that directly correlated with an increase in the fractional Na excretion and was inversely related to age and to an age-dependent increase in salt sensitivity. In contrast, EO excretion increased only transiently in response to NaCl loading and did not vary with age or correlate with fractional Na excretion or salt sensitivity. A positive correlation of both plasma and urine levels of EO and MBG during salt loading may indicate a casual link between two Na pump inhibitors in response to NaCl loading, as observed in animal models. A linear mixed-effects model demonstrated that age, dietary NaCl, renal MBG excretion, and body mass index were each independently associated with systolic blood pressure. Thus, a sustained increase in MBG in response to acutely elevated dietary NaCl is inversely linked to salt sensitivity in normotensive middle-aged and older women, and a relative failure of MBG elaboration by these older persons may be involved in the increased salt sensitivity with advancing age.

[1]  G. Scheiner-Bobis,et al.  Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. , 2007, American journal of physiology. Cell physiology.

[2]  David E. Anderson,et al.  Salt sensitivity of blood pressure is accompanied by slow respiratory rate: results of a clinical feeding study. , 2007, Journal of the American Society of Hypertension : JASH.

[3]  L. Citterio,et al.  Adducin polymorphisms and the treatment of hypertension. , 2007, Pharmacogenomics.

[4]  E. Lakatta,et al.  ANP Differentially Modulates Marinobufagenin-Induced Sodium Pump Inhibition in Kidney and Aorta , 2006, Hypertension.

[5]  P. Manunta,et al.  Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  G. Bianchi,et al.  Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  J. Puschett,et al.  Involvement of Marinobufagenin in a Rat Model of Human Preeclampsia , 2005, American Journal of Nephrology.

[8]  O. Fedorova,et al.  Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension. , 2005, Frontiers in bioscience : a journal and virtual library.

[9]  E. Lakatta,et al.  Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats , 2005, Journal of hypertension.

[10]  E. Lakatta,et al.  Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake , 2005, Journal of hypertension.

[11]  J. Mu,et al.  Blood pressure change with age in salt-sensitive teenagers. , 2004, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[12]  M. Burnier,et al.  Female sex hormones, salt, and blood pressure regulation. , 2004, American journal of hypertension.

[13]  Hirofumi Tanaka,et al.  Dietary Sodium Restriction Rapidly Improves Large Elastic Artery Compliance in Older Adults With Systolic Hypertension , 2004, Hypertension.

[14]  G. MacGregor,et al.  Sodium and blood pressure , 2002, Current opinion in cardiology.

[15]  E. Lakatta,et al.  Endogenous Ligand of &agr;1 Sodium Pump, Marinobufagenin, Is a Novel Mediator of Sodium Chloride–Dependent Hypertension , 2002, Circulation.

[16]  E. Lakatta,et al.  Phorbol Diacetate Potentiates Na+-K+ ATPase Inhibition by a Putative Endogenous Ligand, Marinobufagenin , 2002, Hypertension.

[17]  A. Scuteri,et al.  Racial differences in resting end-tidal CO2 and circulating sodium pump inhibitor. , 2001, American journal of hypertension.

[18]  E. Lakatta,et al.  Marinobufagenin, an Endogenous α-1 Sodium Pump Ligand, in Hypertensive Dahl Salt-Sensitive Rats , 2001 .

[19]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .

[20]  E. Lakatta,et al.  Endogenous Na,K Pump Ligands Are Differentially Regulated During Acute NaCl Loading of Dahl Rats , 2000, Circulation.

[21]  M. Pamnani,et al.  Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings. , 1998, Clinical and experimental hypertension.

[22]  Christopher H. Morrell,et al.  Linear Transformations of Linear Mixed-Effects Models , 1997 .

[23]  P. Manunta,et al.  Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. , 1997, Hypertension.

[24]  M. Weinberger Salt sensitivity: does it play an important role in the pathogenesis and treatment of hypertension? , 1996, Current opinion in nephrology and hypertension.

[25]  O. Fedorova,et al.  Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation. , 1995, Hypertension.

[26]  A. Goto,et al.  Physiology and pharmacology of endogenous digitalis-like factors. , 1992, Pharmacological reviews.

[27]  N. Fineberg,et al.  Sodium and Volume Sensitivity of Blood Pressure Age and Pressure Change Over Time , 1991, Hypertension.

[28]  E. Lakatta Mechanisms of Hypertension in the Elderly , 1989, Journal of the American Geriatrics Society.

[29]  E. Barrett-Connor,et al.  The association between blood pressure, age, and dietary sodium and potassium: a population study. , 1988, Circulation.

[30]  N. Fineberg,et al.  Definitions and Characteristics of Sodium Sensitivity and Blood Pressure Resistance , 1986, Hypertension.

[31]  E. Clarkson,et al.  Concept of natriuretic hormone. , 1985, Physiological reviews.

[32]  M. Pamnani,et al.  Humoral factors and the sodium-potassium pump in volume expanded hypertension. , 1979, Life sciences.

[33]  M. Blaustein Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. , 1977, The American journal of physiology.

[34]  A. H. Norris,et al.  Age-Adjusted Standards for Creatinine Clearance , 1976 .

[35]  A. Hodgkin,et al.  The influence of calcium on sodium efflux in squid axons , 1969, The Journal of physiology.